Obscure gastrointestinal bleeding, iron deficiency anemia , Suspected Crohn’s disease, Suspected small bowel tumors, Surveillance of polyposis syndromes, malabsorption? Celiac disease, nonsteroidal a
Conditions
Interventions
Group A:20%Mannitol, 0.9% saline
Group B:20%Mannitol, 0.9% saline?simethicone
Group C:20%Mannitol, 0.9% saline?simethicone
Sponsors
Sanming First Affiliated Hospital of Fujian Medical University
Eligibility
Sex/Gender
All
Age
10 Years to 85 Years
Inclusion criteria
Inclusion criteria: Obscure gastrointestinal bleeding, iron deficiency anemia, Suspected Crohn's disease, Suspected small bowel tumors, Surveillance of polyposis syndromes, malabsorption, Celiac disease, nonsteroidal anti-inflammatory drug (NSAID)-induced small bowel injury, unexplained chronic abdominal pain, unexplained chronic diarrhea and Suspected gastrointestinal functional disease.
Exclusion criteria
Exclusion criteria: history of gastrointestinal or abdominal surgery, known or suspected small intestinal obstruction, fistulas or strictures,swallowing abnormalities, Pregnancy, thyroid disease, diabetes mellitus, chronic renal or hepatic or cardiac failure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The level of small bowel cleaning; | — |
Countries
China
Contacts
Public ContactChen Hongbin
Department of Gastroenterology, Sanming First Affiliated Hospital of Fujian Medical University
Outcome results
None listed